MedPath

Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer

Not Applicable
Completed
Conditions
Rectal Cancer
Interventions
Procedure: Laparoscopic Total Mesorectal Excision
Procedure: transanal total mesorectal excision
Registration Number
NCT06147492
Lead Sponsor
Yanhong Deng
Brief Summary

A comprehensive study with prospectively collected data. These patients were assigned to either the taTME group or the laTME group according to the surgery procedure received

Detailed Description

Transanal total mesorectal excision has emerged as a potential solution to certain limitations associated with laparoscopic total mesorectal excision in rectal cancer patients. Differences in surgical approaches have raised questions regarding their impact on the risk of postoperative urinary retention, with limited data available from large scale study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
526
Inclusion Criteria
  • Age range from 18 to 65 years,
  • Diagnosed with rectal cancer at clinical tumor node metastasis stages II or III.
  • Palpable tumor determined by digital rectal examination or proctoscopy
  • The distal border of the tumor located within 12 cm from the anal verge
Exclusion Criteria
  • Patients presenting clear indications of pelvic side wall involvement or distant metastasis
  • Uncontrolled hypertension or cardiovascular disease
  • Patients with synchronous colon cancer
  • History of other malignancies within the past 5 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laTMELaparoscopic Total Mesorectal ExcisionLaparoscopic Total Mesorectal Excision
taTMEtransanal total mesorectal excisiona transanal bottom-up approach was employed for the Total Mesorectal Excision procedure
taTMELaparoscopic Total Mesorectal Excisiona transanal bottom-up approach was employed for the Total Mesorectal Excision procedure
Primary Outcome Measures
NameTimeMethod
urinary retention30 days

urinary retention rate

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath